Nasal spray alternative to EpiPen suffers setback as FDA seeks fresh study; Exclusive-U.S. FDA found lapses at Novo’s main U.S. factory in May 2022 -report and more
Following is a summary of current health news briefs. Nasal spray alternative to EpiPen suffers setback as FDA seeks fresh study The U.S. health regulator has declined to approve...
Read more













